{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:21Z","timestamp":1740108441851,"version":"3.37.3"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T00:00:00Z","timestamp":1558310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00296-019-04325-5","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:06:05Z","timestamp":1558555565000},"page":"1307-1319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rheumatology training and research in Iran"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6967","authenticated-orcid":false,"given":"Alireza","family":"Khabbazi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3813-0188","authenticated-orcid":false,"given":"Mohsen","family":"Soroosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,20]]},"reference":[{"issue":"7","key":"4325_CR1","first-page":"1384","volume":"35","author":"F Davatchi","year":"2008","unstructured":"Davatchi F, Jamshidi AR, Banihashemi AT et al (2008) WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol 35(7):1384","journal-title":"J Rheumatol"},{"issue":"11","key":"4325_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/1756-185X.12809","volume":"19","author":"F Davatchi","year":"2016","unstructured":"Davatchi F, Sandoughi M, Moghimi N et al (2016) Epidemiology of rheumatic diseases in Iran from analysis of four COPCORD studies. Int J Rheum Dis 19(11):1056\u20131062. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12809","journal-title":"Int J Rheum Dis"},{"issue":"9","key":"4325_CR3","first-page":"759","volume":"18","author":"AD Irani","year":"2013","unstructured":"Irani AD, Poorolajal J, Khalilian A, Esmailnasab N, Cheraghi Z (2013) Prevalence of osteoporosis in Iran: a meta-analysis. J Res Med Sci 18(9):759\u2013766","journal-title":"J Res Med Sci"},{"issue":"1","key":"4325_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1478-7954-7-9","volume":"4","author":"M Naghavi","year":"2009","unstructured":"Naghavi M, Abolhassani F, Pourmalek F et al (2009) The burden of disease and injury in Iran in the year 2003. Popul Health Metr 4(1):1\u201319. \n                    https:\/\/doi.org\/10.1186\/1478-7954-7-9","journal-title":"Popul Health Metr"},{"key":"4325_CR5","unstructured":"Ministry of Health and Medical Education. Deputy of Education. \n                    http:\/\/dme.behdasht.gov.ir\/index.aspx\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1756-185X.2009.01425.x","volume":"12","author":"Fereydoun Davatchi","year":"2009","unstructured":"Davatchi Fereydoun (2009) Rheumatology in Iran. Int J Rheum Dis 12:283\u2013287. \n                    https:\/\/doi.org\/10.1111\/j.1756-185X.2009.01425.x","journal-title":"Int J Rheum Dis"},{"key":"4325_CR7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. \n                    https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4325_CR8","unstructured":"Iranian Rheumatology Association. About-us. \n                    http:\/\/iranianra.ir\/page\/142\/About-us\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR9","unstructured":"Rheumatology Research Center. \n                    http:\/\/rrc.tums.ac.ir\/page\/view\/id\/3?lang=fa\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR10","unstructured":"Continuing Medical Education. \n                    http:\/\/cehp.behdasht.gov.ir\/index.aspx\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR11","unstructured":"Scientology system of faculty members. \n                    http:\/\/isid.research.ac.ir\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR12","unstructured":"Tehran University of Medical Sciences. History of School of Medicine. \n                    http:\/\/medicine.tums.ac.ir\/college\/fa\n                    \n                  . Last updated 10 May 2019. Accessed 10 May 2019"},{"key":"4325_CR13","unstructured":"Ministry of Health and Medical Education. Food and Drug Administration. Biologic medications. \n                    http:\/\/fda.gov.ir\n                    \n                  . Last updated 30 Apr 2018. Accessed 10 May 2019"},{"key":"4325_CR14","doi-asserted-by":"publisher","unstructured":"Deshpande S (2014) History of rheumatology. Med J Dr. D.Y. Patil Univ 7(2):119\u2013123. \n                    https:\/\/doi.org\/10.4103\/0975-2870.126307","DOI":"10.4103\/0975-2870.126307"},{"key":"4325_CR15","unstructured":"Tehran University Medical Journal. TUMS Publications. \n                    http:\/\/tumj.tums.ac.ir\n                    \n                  . Last updated 10 May 2019. Accessed 10 May 2019"},{"key":"4325_CR16","unstructured":"Tabriz University of Medical Sciences. History. \n                    https:\/\/www.tbzmed.ac.ir\/?PageID=111\n                    \n                  . Last updated 9 May 2019. Accessed 10 May 2019"},{"key":"4325_CR17","unstructured":"Wikipedia. Tabriz University of Medical Sciences. \n                    https:\/\/en.wikipedia.org\/wiki\/Tabriz_University_of_Medical_Sciences\n                    \n                  . Last updated 28 Nov 2018. Accessed 10 May 2019"},{"issue":"3","key":"4325_CR18","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10067-013-2430-0","volume":"34","author":"N Moghimi","year":"2015","unstructured":"Moghimi N, Davatchi F, Rahimi E et al (2015) WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran. Clin Rheumatol 34(3):535\u2013543. \n                    https:\/\/doi.org\/10.1007\/s10067-013-2430-0","journal-title":"Clin Rheumatol"},{"issue":"5","key":"4325_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/1756-185X.12110","volume":"16","author":"M Sandoughi","year":"2013","unstructured":"Sandoughi M, Zakeri Z, Tehrani Banihashemi A et al (2013) Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study). Int J Rheum Dis 16(5):509\u2013517. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12110","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"4325_CR20","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s10067-009-1234-8","volume":"28","author":"F Davatchi","year":"2009","unstructured":"Davatchi F, Tehrani Banihashemi A, Gholami J et al (2009) The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran. Clin Rheumatol 28(11):1267\u20131274. \n                    https:\/\/doi.org\/10.1007\/s10067-009-1234-8","journal-title":"Clin Rheumatol"},{"key":"4325_CR21","unstructured":"SCOPUS. Advanced search. \n                    https:\/\/www.scopus.com\/search\/form.uri?display=basic\n                    \n                  . Last updated 10 May 2019. Accessed 10 May 2019"},{"issue":"4","key":"4325_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00296-017-3661-1","volume":"37","author":"S Kolahi","year":"2017","unstructured":"Kolahi S, Khabbazi A, Malek Mahdavi A et al (2017) Prevalence of musculoskeletal disorders in Azar cohort population in Northwest of Iran. Rheumatol Int 37(4):495\u2013502. \n                    https:\/\/doi.org\/10.1007\/s00296-017-3661-1","journal-title":"Rheumatol Int"},{"issue":"10","key":"4325_CR23","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/art.24737","volume":"61","author":"S Dahaghin","year":"2009","unstructured":"Dahaghin S, Tehrani-Banihashemi SA, Faezi ST, Jamshidi AR, Davatchi F (2009) Squatting, sitting on the floor, or cycling: are life-long daily activities risk factors for clinical knee osteoarthritis? Stage III results of a community-based study. Arthritis Rheum 61(10):1337\u20131342. \n                    https:\/\/doi.org\/10.1002\/art.24737","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4325_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4103\/1735-9066.185595","volume":"21","author":"SH Panah","year":"2016","unstructured":"Panah SH, Baharlouie H, Rezaeian ZS, Hawker G (2016) Cross-cultural adaptation and validation of the Persian version of the Intermittent and Constant Osteoarthritis Pain Measure for the knee. Iran J Nurs Midwifery Res 21(4):417\u2013423. \n                    https:\/\/doi.org\/10.4103\/1735-9066.185595","journal-title":"Iran J Nurs Midwifery Res"},{"issue":"25","key":"4325_CR25","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3109\/09638280902918746","volume":"31","author":"AR Askary-Ashtiani","year":"2009","unstructured":"Askary-Ashtiani AR, Mousavi SJ, Montazeri A, Shamsollahi S, Parnianpour M (2009) Cultural adaptation and validation of the Persian version of the Arthritis Impact Measurement Scales 2-Short Form in patients with osteoarthritis of the knee. Disabil Rehabil 31(25):2081\u20132087. \n                    https:\/\/doi.org\/10.3109\/09638280902918746","journal-title":"Disabil Rehabil"},{"issue":"5","key":"4325_CR26","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00296-016-3645-6","volume":"37","author":"A Kordi Yoosefinejad","year":"2017","unstructured":"Kordi Yoosefinejad A, Motealleh A, Babakhani M (2017) Evaluation of validity and reliability of the Persian version of the functional index of hand osteoarthritis. Rheumatol Int 37(5):719\u2013725. \n                    https:\/\/doi.org\/10.1007\/s00296-016-3645-6","journal-title":"Rheumatol Int"},{"issue":"4","key":"4325_CR27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.joca.2011.01.010","volume":"19","author":"M Salavati","year":"2011","unstructured":"Salavati M, Akhbari B, Mohammadi F, Mazaheri M, Khorrami M (2011) Knee injury and Osteoarthritis Outcome Score (KOOS); reliability and validity in competitive athletes after anterior cruciate ligament reconstruction. Osteoarthr Cartil 19(4):406\u2013410. \n                    https:\/\/doi.org\/10.1016\/j.joca.2011.01.010","journal-title":"Osteoarthr Cartil"},{"key":"4325_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2474-10-95","volume":"10","author":"SJ Mousavi","year":"2009","unstructured":"Mousavi SJ, Parnianpour M, Askary-Ashtiani AR, Hadian MR, Rostamian A, Montazeri A (2009) Translation and validation study of the Persian version of the Arthritis Impact Measurement Scales 2 (AIMS2) in patients with osteoarthritis of the knee. BMC Musculoskelet Disord 10:95. \n                    https:\/\/doi.org\/10.1186\/1471-2474-10-95","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"4325_CR29","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s10067-012-1983-7","volume":"31","author":"H Nadrian","year":"2012","unstructured":"Nadrian H, Moghimi N, Nadrian E, Moradzadeh R, Bahmanpour K, Iranpour A, Bellamy N (2012) Validity and reliability of the Persian versions of WOMAC Osteoarthritis Index and Lequesne Algofunctional Index. Clin Rheumatol 31(7):1097\u20131102. \n                    https:\/\/doi.org\/10.1007\/s10067-012-1983-7","journal-title":"Clin Rheumatol"},{"issue":"11","key":"4325_CR30","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ptr.5174","volume":"28","author":"Y Panahi","year":"2016","unstructured":"Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A (2016) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res 28(11):1625\u20131631. \n                    https:\/\/doi.org\/10.1002\/ptr.5174","journal-title":"Phytother Res"},{"issue":"3","key":"4325_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/1756-185X.12477","volume":"19","author":"L Maghsoumi-Norouzabad","year":"2016","unstructured":"Maghsoumi-Norouzabad L, Alipoor B, Abed R, Eftekhar Sadat B, Mesgari-Abbasi M, Asghari Jafarabadi M (2016) Effects of Arctium lappa L. (Burdock) root tea on inflammatory status and oxidative stress in patients with knee osteoarthritis. Int J Rheum Dis 19(3):255\u2013261. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12477","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"4325_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ctcp.2015.06.003","volume":"21","author":"R Shoara","year":"2015","unstructured":"Shoara R, Hashempur MH, Ashraf A, Salehi A, Dehshahri S, Habibagahi Z (2015) Efficacy and safety of topical Matricaria chamomilla L. (chamomile) oil for knee osteoarthritis: a randomized controlled clinical trial. Complement Ther Clin Pract 21(3):181\u2013187. \n                    https:\/\/doi.org\/10.1016\/j.ctcp.2015.06.003","journal-title":"Complement Ther Clin Pract"},{"key":"4325_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.17179\/excli2015-639","volume":"15","author":"Y Panahi","year":"2016","unstructured":"Panahi Y, Alishiri GH, Bayat N, Hosseini SM, Sahebkar A (2016) Efficacy of Elaeagnus angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial. EXCLI J 15:203\u2013210. \n                    https:\/\/doi.org\/10.17179\/excli2015-639","journal-title":"EXCLI J"},{"issue":"1","key":"4325_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.clnu.2016.12.004","volume":"37","author":"MH Hashempur","year":"2018","unstructured":"Hashempur MH, Sadrneshin S, Mosavat SH, Ashraf A (2018) Green tea (Camellia sinensis) for patients with knee osteoarthritis: a randomized open-label active-controlled clinical trial. Clin Nutr 37(1):85\u201390. \n                    https:\/\/doi.org\/10.1016\/j.clnu.2016.12.004","journal-title":"Clin Nutr"},{"issue":"2","key":"4325_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/2156587214566867","volume":"20","author":"Z Abolhassanzadeh","year":"2015","unstructured":"Abolhassanzadeh Z, Aflaki E, Yousefi G, Mohagheghzadeh A (2015) Randomized clinical trial of peganum oil for knee osteoarthritis. J Evid Based Complementary Altern Med 20(2):126\u2013131. \n                    https:\/\/doi.org\/10.1177\/2156587214566867","journal-title":"J Evid Based Complementary Altern Med"},{"issue":"13","key":"4325_CR36","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1002\/jsfa.7647","volume":"96","author":"N Ghoochani","year":"2016","unstructured":"Ghoochani N, Karandish M, Mowla K, Haghighizadeh MH, Jalali MT (2016) The effect of pomegranate juice on clinical signs, matrix metalloproteinases and antioxidant status in patients with knee osteoarthritis. J Sci Food Agric 96(13):4377\u20134381. \n                    https:\/\/doi.org\/10.1002\/jsfa.7647","journal-title":"J Sci Food Agric"},{"issue":"4","key":"4325_CR37","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2458-4-38","volume":"25","author":"S Hashemipour","year":"2004","unstructured":"Hashemipour S, Larijani B, Adibi H et al (2004) Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health 25(4):38. \n                    https:\/\/doi.org\/10.1186\/1471-2458-4-38","journal-title":"BMC Public Health"},{"issue":"3","key":"4325_CR38","first-page":"45","volume":"39","author":"Z Rahnavard","year":"2010","unstructured":"Rahnavard Z, Eybpoosh S, Homami MR et al (2010) Vitamin d deficiency in healthy male population: results of the Iranian multi- center osteoporosis study. Iran J Public Health 39(3):45\u201352","journal-title":"Iran J Public Health"},{"issue":"10","key":"4325_CR39","first-page":"52","volume":"41","author":"A Keramat","year":"2012","unstructured":"Keramat A, Larigani B, Adibi H (2012) Risk factors for spinal osteoporosis as compared with femoral osteoporosis in urban Iranian women. Iran J Public Health 41(10):52\u201359","journal-title":"Iran J Public Health"},{"issue":"28","key":"4325_CR40","first-page":"94","volume":"15","author":"A Ahmadzadeh","year":"2014","unstructured":"Ahmadzadeh A, Emam M, Rajaei A, Moslemizadeh M, Jalessi M (2014) Comparison of three different osteoporosis risk assessment tools: ORAI (osteoporosis risk assessment instrument), SCORE (simple calculated osteoporosis risk estimation) and OST (osteoporosis self-assessment tool). Med J Islam Repub Iran 15(28):94","journal-title":"Med J Islam Repub Iran"},{"key":"4325_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14196\/mjiri.31.39","volume":"31","author":"AA Ebadifardazar","year":"2017","unstructured":"Ebadifardazar AA, Rezapour A, Alipour V, Sarabi-Asiabar A, Gray S, Mobinizadeh M, Yousefvand M, Arabloo J (2017) Cost-effectiveness of teriparatide compared with alendronate and risedronate for the treatment of postmenopausal osteoporosis patients in Iran. Med J Islam Repub Iran 31:39. \n                    https:\/\/doi.org\/10.14196\/mjiri.31.39","journal-title":"Med J Islam Repub Iran"},{"issue":"1","key":"4325_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1756-185x.2011.01664.x","volume":"15","author":"M Hajalilou","year":"2012","unstructured":"Hajalilou M, Noshad H, Khabbazi AR, Kolahi S, Azari MH, Abbasneghad M (2012) Familial rheumatoid arthritis in patients referred to rheumatology clinics of Tabriz, Iran. Int J Rheum Dis 15(1):110\u2013115. \n                    https:\/\/doi.org\/10.1111\/j.1756-185x.2011.01664.x","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"4325_CR43","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1002\/jcp.27379","volume":"234","author":"S Korani","year":"2019","unstructured":"Korani S, Korani M, Butler AE, Sahebkar A (2019) Genetics and rheumatoid arthritis susceptibility in Iran. J Cell Physiol 234(5):5578\u20135587. \n                    https:\/\/doi.org\/10.1002\/jcp.27379","journal-title":"J Cell Physiol"},{"issue":"12","key":"4325_CR44","doi-asserted-by":"publisher","first-page":"e26874","DOI":"10.5812\/ircmj.26874","volume":"18","author":"N Ghamarzad Shishavan","year":"2016","unstructured":"Ghamarzad Shishavan N, Pirouzpanah P, Hajialilo M et al (2016) Risk factors of rheumatoid arthritis development among females in north-west of Iran: a case\u2013control study. Iran Red Crescent Med J 18(12):e26874. \n                    https:\/\/doi.org\/10.5812\/ircmj.26874","journal-title":"Iran Red Crescent Med J"},{"issue":"5","key":"4325_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1756-185X.2012.01766.x","volume":"15","author":"F Davatchi","year":"2012","unstructured":"Davatchi F, Abari IS, Soroosh S, Soroosh M, Sadeghi Abdollahi B (2012) Performance of the 2010 rheumatoid arthritis classification criteria. Int J Rheum Dis 15(5):455\u2013461. \n                    https:\/\/doi.org\/10.1111\/j.1756-185X.2012.01766.x","journal-title":"Int J Rheum Dis"},{"key":"4325_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1479-8077.2006.00166.x","volume":"9","author":"F Davatchi","year":"2006","unstructured":"Davatchi F, Akbarian M, Shahram F, Nadji A, Gharibdoost F, Jamshidi AR (2006) DMARD combination therapy in rheumatoid arthritis: 5-year follow-up results in a daily practice setting. APLAR J Rheumatol 9:60\u201363. \n                    https:\/\/doi.org\/10.1111\/j.1479-8077.2006.00166.x","journal-title":"APLAR J Rheumatol"},{"issue":"6","key":"4325_CR47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/1756-185X.12416","volume":"17","author":"A Khabbazi","year":"2014","unstructured":"Khabbazi A, Kolahi S, Dastgiri S et al (2014) Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate. Int J Rheum Dis 17(6):646\u2013652. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12416","journal-title":"Int J Rheum Dis"},{"issue":"7","key":"4325_CR48","first-page":"448","volume":"54","author":"A Hajiabbasi","year":"2016","unstructured":"Hajiabbasi A, Shenavar Masooleh I, Alizadeh Y, Banikarimi AS, Ghavidel Parsa P (2016) Secondary Sjogren\u2019s syndrome in 83 patients with rheumatoid arthritis. Acta Med Iran 54(7):448\u2013453","journal-title":"Acta Med Iran"},{"issue":"16","key":"4325_CR49","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3923\/pjbs.2011.812.816","volume":"14","author":"A Shakeri","year":"2011","unstructured":"Shakeri A, Bazzaz MB, Khabbazi A, Fouladi RF (2011) Common carotid intima\u2013media thickness in patients with late rheumatoid arthritis: what is the role of gender? Pak J Biol Sci 14(16):812\u2013816","journal-title":"Pak J Biol Sci"},{"issue":"4","key":"4325_CR50","doi-asserted-by":"publisher","first-page":"e11798","DOI":"10.5812\/ircmj.11798","volume":"16","author":"M Hajialilo","year":"2014","unstructured":"Hajialilo M, Ghorbanihaghjo A, Khabbazi A, Kolahi S, Rashtchizadeh N (2014) Ankylosing spondylitis in Iran; late diagnosis and its causes. Iran Red Crescent Med J 16(4):e11798. \n                    https:\/\/doi.org\/10.5812\/ircmj.11798","journal-title":"Iran Red Crescent Med J"},{"issue":"3","key":"4325_CR51","doi-asserted-by":"publisher","first-page":"499","DOI":"10.3109\/14397595.2013.844302","volume":"24","author":"AR Jamshidi","year":"2014","unstructured":"Jamshidi AR, Shahlaee A, Farhadi E, Fallahi S et al (2014) Clinical characteristics and medical management of Iranian patients with ankylosing spondylitis. Mod Rheumatol 24(3):499\u2013504. \n                    https:\/\/doi.org\/10.3109\/14397595.2013.844302","journal-title":"Mod Rheumatol"},{"issue":"2","key":"4325_CR52","first-page":"162","volume":"11","author":"F Jamshidi","year":"2008","unstructured":"Jamshidi F, Bouzari N, Seirafi H, Farnaghi F, Firooz A (2008) The prevalence of psoriatic arthritis in psoriatic patients in Tehran, Iran. Arch Iran Med 11(2):162\u2013165","journal-title":"Arch Iran Med"},{"issue":"3","key":"4325_CR53","first-page":"279","volume":"12","author":"M Moghaddassi","year":"2009","unstructured":"Moghaddassi M, Shahram F, Chams-Davatchi C, Najafizadeh SR, Davatchi F (2009) Different aspects of psoriasis: analysis of 150 Iranian patients. Arch Iran Med 12(3):279\u2013283","journal-title":"Arch Iran Med"},{"issue":"4","key":"4325_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1756-185X.2010.01547.x","volume":"13","author":"M Akbarian","year":"2010","unstructured":"Akbarian M, Faezi ST, Gharibdoost F et al (2010) Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. Int J Rheum Dis 13(4):374\u2013379. \n                    https:\/\/doi.org\/10.1111\/j.1756-185X.2010.01547.x","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"4325_CR55","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/0961203307086509","volume":"17","author":"MA Nazarinia","year":"2008","unstructured":"Nazarinia MA, Ghaffarpasand F, Shamsdin A, Karimi AA, Abbasi N, Amiri A (2008) Systemic lupus erythematosus in the Fars Province of Iran. Lupus 17(3):221\u2013227. \n                    https:\/\/doi.org\/10.1177\/0961203307086509","journal-title":"Lupus"},{"issue":"2","key":"4325_CR56","first-page":"41","volume":"5","author":"G Espandar","year":"2016","unstructured":"Espandar G, Moghimi J, Ghorbani R, Pourazizi M, Seiri MA, Khosravi S (2016) Retinal toxicity in patients treated with hydroxychloroquine: a cross-sectional study. Med Hypothesis Discov Innov Ophthalmol 5(2):41\u201346","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"issue":"2","key":"4325_CR57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ejr.2014.06.006","volume":"37","author":"M Hajialiloa","year":"2014","unstructured":"Hajialiloa M, Ghorbanihaghjo A, Khabbazia A (2014) Nasal carriage rate of Staphylococcus aureus among patients with systemic lupus erythematosus and its correlation with disease relapse. Egypt Rheumatol 37(2):81\u201384. \n                    https:\/\/doi.org\/10.1016\/j.ejr.2014.06.006","journal-title":"Egypt Rheumatol"},{"issue":"5","key":"4325_CR58","first-page":"288","volume":"12","author":"L Gadakchi","year":"2018","unstructured":"Gadakchi L, Hajialilo M, Nakhjavani MR et al (2018) Efficacy and safety of mycophenolate mofetil versus intravenous pulse cyclophosphamide as induction therapy in proliferative lupus nephritis. Iran J Kidney Dis 12(5):288\u2013292","journal-title":"Iran J Kidney Dis"},{"issue":"3","key":"4325_CR59","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14397595.2017.1352479","volume":"28","author":"M Sheikholeslami","year":"2018","unstructured":"Sheikholeslami M, Hajialilo M, Rasi Hashemi SS, Malek Mahdavi A, Gojazadeh M, Khabbazi A (2018) Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis. Mod Rheumatol 28(3):523\u2013529. \n                    https:\/\/doi.org\/10.1080\/14397595.2017.1352479","journal-title":"Mod Rheumatol"},{"issue":"10","key":"4325_CR60","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1177\/0961203317696588","volume":"26","author":"M Pakfetrat","year":"2017","unstructured":"Pakfetrat M, Malekmakan L, Kamranpour M, Tadayon T (2017) A five consecutive years\u2019 study of renal function outcome among biopsy proven lupus nephritis patients in Southern Iran. Lupus 26(10):1082\u20131088. \n                    https:\/\/doi.org\/10.1177\/0961203317696588","journal-title":"Lupus"},{"issue":"1","key":"4325_CR61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.transproceed.2007.12.013","volume":"40","author":"A Ghafari","year":"2008","unstructured":"Ghafari A, Etemadi J, Ardalan MR (2008) Renal transplantation in patients with lupus nephritis: a single-center experience. Transpl Proc 40(1):143\u2013144. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2007.12.013","journal-title":"Transpl Proc"},{"issue":"2","key":"4325_CR62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/rheumatology\/key281","volume":"58","author":"D Gonz\u00e1lez-Serna","year":"2019","unstructured":"Gonz\u00e1lez-Serna D, L\u00f3pez-Isac E, Yilmaz N et al (2019) Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study. Rheumatology (Oxford) 58(2):289\u2013298. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key281","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"4325_CR63","first-page":"228","volume":"16","author":"B Yousefi","year":"2017","unstructured":"Yousefi B, Mahmoudi M, Sarafnejad A et al (2017) Downregulation of Aquaporin3 in systemic sclerosis dermal fibroblasts. Iran J Allergy Asthma Immunol 16(3):228\u2013234","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"3","key":"4325_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00296-017-3915-y","volume":"38","author":"N Dashti","year":"2018","unstructured":"Dashti N, Mahmoudi M, Gharibdoost F et al (2018) Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis. Rheumatol Int 38(3):489\u2013498. \n                    https:\/\/doi.org\/10.1007\/s00296-017-3915-y","journal-title":"Rheumatol Int"},{"issue":"5","key":"4325_CR65","first-page":"74","volume":"100","author":"MA Nazarinia","year":"2016","unstructured":"Nazarinia MA, Esmaeilzadeh E, Emami Y, Salehi A (2016) One decade distinct features, morbidity and mortality of scleroderma: a cross-sectional study. Clin Exp Rheumatol 100(5):74\u201378","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"4325_CR66","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00296-016-3475-6","volume":"36","author":"H Poormoghim","year":"2016","unstructured":"Poormoghim H, Andalib E, Jalali A, Ghaderi A, Ghorbannia A, Mojtabavi N (2016) Survival and causes of death in systemic sclerosis patients: a single center registry report from Iran. Rheumatol Int 36(7):925\u2013934. \n                    https:\/\/doi.org\/10.1007\/s00296-016-3475-6","journal-title":"Rheumatol Int"},{"issue":"8","key":"4325_CR67","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/1756-185X.13352","volume":"21","author":"M Hajialilo","year":"2018","unstructured":"Hajialilo M, Ghorbanihaghjo A, Khabbazi A et al (2018) Long-term follow-up of 76 Iranian patients with idiopathic inflammatory myopathies. Int J Rheum Dis 21(8):1627\u20131633. \n                    https:\/\/doi.org\/10.1111\/1756-185X.13352","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"4325_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/0028-3886.60398","volume":"58","author":"P Naji","year":"2010","unstructured":"Naji P, Shahram F, Nadji A, Davatchi F (2010) Effect of early treatment in polymyositis and dermatomyositis. Neurol India 58(1):58\u201361. \n                    https:\/\/doi.org\/10.4103\/0028-3886.60398","journal-title":"Neurol India"},{"issue":"11","key":"4325_CR69","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10067-009-1235-7","volume":"28","author":"F Davatchi","year":"2009","unstructured":"Davatchi F, Jamshidi AR, Tehrani Banihashemi A (2009) Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran. Clin Rheumatol 28(11):1275\u20131282. \n                    https:\/\/doi.org\/10.1007\/s10067-009-1235-7","journal-title":"Clin Rheumatol"},{"key":"4325_CR70","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.biopha.2017.04.106","volume":"91","author":"S Alipour","year":"2017","unstructured":"Alipour S, Nouri M, Sakhinia E et al (2017) Epigenetic alterations in chronic disease focusing on Behcet\u2019s disease: review. Biomed Pharmacother 91:526\u2013533. \n                    https:\/\/doi.org\/10.1016\/j.biopha.2017.04.106","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"4325_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13075-015-0585-6","volume":"19","author":"JM Xavier","year":"2015","unstructured":"Xavier JM, Davatchi F, Abade O et al (2015) Characterization of the major histocompatibility complex locus association with Behcet\u2019s disease in Iran. Arthritis Res Ther 19(17):81. \n                    https:\/\/doi.org\/10.1186\/s13075-015-0585-6","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"4325_CR72","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/art.34437","volume":"64","author":"JM Xavier","year":"2012","unstructured":"Xavier JM, Shahram F, Davatchi F et al (2012) Association study of IL10 and IL23R-IL12RB2 in Iranian patients with Behcet\u2019s disease. Arthritis Rheum 64(8):2761\u20132772. \n                    https:\/\/doi.org\/10.1002\/art.34437","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4325_CR73","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/03009742.2011.562532","volume":"40","author":"M Esmaeili","year":"2011","unstructured":"Esmaeili M, Bonyadi M, Khabbazi A et al (2011) Common MEFV mutations in Iranian Azeri Turkish patients with Beh\u00e7et\u2019s disease. Scand J Rheumatol 40(5):383\u2013386. \n                    https:\/\/doi.org\/10.3109\/03009742.2011.562532","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"4325_CR74","first-page":"1897","volume":"61","author":"A Hosseini","year":"2015","unstructured":"Hosseini A, Shanehbandi D, Estiar MA et al (2015) A single nucleotide polymorphism in the FOXP3 gene associated with Behcet\u2019s disease in an Iranian population. Clin Lab 61(12):1897\u20131903","journal-title":"Clin Lab"},{"key":"4325_CR75","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.imlet.2017.12.008","volume":"194","author":"B Afkari","year":"2018","unstructured":"Afkari B, Babaloo Z, Dolati S et al (2018) Molecular analysis of interleukin-10 gene polymorphisms in patients with Behcet\u2019s disease. Immunol Lett 194:56\u201361. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2017.12.008","journal-title":"Immunol Lett"},{"key":"4325_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2018.06.006","author":"S Alipour","year":"2018","unstructured":"Alipour S, Sakhinia E, Khabbazi A et al (2018) Methylation status of interleukin-6 gene promoter in patients with Behcet\u2019s disease. Rheumatol Clin. \n                    https:\/\/doi.org\/10.1016\/j.reuma.2018.06.006","journal-title":"Rheumatol Clin"},{"issue":"8","key":"4325_CR77","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1002\/jcb.26809","volume":"119","author":"S Alipour","year":"2018","unstructured":"Alipour S, Nouri M, Khabbazi A et al (2018) Hypermethylation of IL-10 gene is responsible for its low mRNA expression in Behcet\u2019s disease. J Cell Biochem 119(8):6614\u20136622. \n                    https:\/\/doi.org\/10.1002\/jcb.26809","journal-title":"J Cell Biochem"},{"key":"4325_CR78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.imlet.2018.10.012","volume":"204","author":"S Kolahi","year":"2018","unstructured":"Kolahi S, Farajzadeh MJ, Alipour S et al (2018) Determination of mir-155 and mir-146a expression rates and its association with expression level of TNF-\u03b1 and CTLA4 genes in patients with Behcet\u2019s disease. Immunol Lett 204:55\u201359. \n                    https:\/\/doi.org\/10.1016\/j.imlet.2018.10.012","journal-title":"Immunol Lett"},{"issue":"4","key":"4325_CR79","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/jcp.27207","volume":"234","author":"M Ahmadi","year":"2019","unstructured":"Ahmadi M, Yousefi M, Abbaspour-Aghdam S et al (2019) Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet\u2019s disease. J Cell Physiol 234(4):3985\u20133994. \n                    https:\/\/doi.org\/10.1002\/jcp.27207","journal-title":"J Cell Physiol"},{"issue":"4","key":"4325_CR80","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/1756-185X.12153","volume":"17","author":"A Khabbazi","year":"2014","unstructured":"Khabbazi A, Rashtchizadeh N, Ghorbanihaghjo A et al (2014) The status of serum vitamin D in patients with active Behcet\u2019s disease compared with controls. Int J Rheum Dis 17(4):430\u2013434. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12153","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"4325_CR81","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/03009742.2014.945477","volume":"44","author":"S Kolahi","year":"2015","unstructured":"Kolahi S, Khabbazi A, Khodadadi H et al (2015) Vitamin D receptor gene polymorphisms in Iranian Azary patients with Behcet\u2019s disease. Scand J Rheumatol 44(2):163\u2013167. \n                    https:\/\/doi.org\/10.3109\/03009742.2014.945477","journal-title":"Scand J Rheumatol"},{"key":"4325_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1493065","volume":"29","author":"A Malek Mahdavi","year":"2018","unstructured":"Malek Mahdavi A, Khabbazi A, Yaaghoobian B et al (2018) Cigarette smoking and risk of Behcet\u2019s disease: a propensity score matching analysis. Mod Rheumatol 29:1\u20137. \n                    https:\/\/doi.org\/10.1080\/14397595.2018.1493065","journal-title":"Mod Rheumatol"},{"key":"4325_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1558752","volume":"17","author":"F Davatchi","year":"2018","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C et al (2018) Behcet\u2019s disease in Iran: analysis of 7641 cases. Mod Rheumatol 17:1\u20138. \n                    https:\/\/doi.org\/10.1080\/14397595.2018.1558752","journal-title":"Mod Rheumatol"},{"issue":"5","key":"4325_CR84","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1111\/1756-185x.12512","volume":"21","author":"A Khabbazi","year":"2018","unstructured":"Khabbazi A, Noshad H, Shayan FK, Kavandi H, Hajialiloo M, Kolahi S (2018) Demographic and clinical features of Behcet\u2019s disease in Azerbaijan. Int J Rheum Dis 21(5):1114\u20131119. \n                    https:\/\/doi.org\/10.1111\/1756-185x.12512","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"4325_CR85","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10165-009-0191-z","volume":"19","author":"F Shahram","year":"2009","unstructured":"Shahram F, Khabbazi A, Nadji A, Ziaie N, Banihashemi AT, Davatchi F (2009) Comparison of existing disease activity indices in the follow-up of patients with Behcet\u2019s disease. Mod Rheumatol 19(5):536\u2013541. \n                    https:\/\/doi.org\/10.1007\/s10165-009-0191-z","journal-title":"Mod Rheumatol"},{"issue":"3","key":"4325_CR86","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease (ITR-ICBD)","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Behcet\u2019s Disease (ITR-ICBD) (2014) The International Criteria for Behcet\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338\u2013347. \n                    https:\/\/doi.org\/10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"4325_CR87","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10067-013-2411-3","volume":"34","author":"F Davatchi","year":"2015","unstructured":"Davatchi F, Abdollahi BS, Chams-Davatchi C et al (2015) Validation of the revised International Criteria for Behcet\u2019s Disease (ICBD) in Iran. Clin Rheumatol 34(2):315\u2013320. \n                    https:\/\/doi.org\/10.1007\/s10067-013-2411-3","journal-title":"Clin Rheumatol"},{"issue":"3","key":"4325_CR88","doi-asserted-by":"publisher","first-page":"82","DOI":"10.15171\/jarcm.2017.016","volume":"5","author":"L Delnabi","year":"2017","unstructured":"Delnabi L, Gojazadeh M, Hajialilo M, Ebrahimi A, Khabbazi A (2017) Comparison of International Study Group Criteria and International Criteria for Behcet\u2019s Disease in the Azeri population of Iran. J Anal Res Clin Med 5(3):82\u201385. \n                    https:\/\/doi.org\/10.15171\/jarcm.2017.016","journal-title":"J Anal Res Clin Med"},{"issue":"8","key":"4325_CR89","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s10067-010-1430-6","volume":"29","author":"F Davatchi","year":"2010","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C et al (2010) Behcet\u2019s disease: from East to West. Clin Rheumatol 29(8):823\u2013833. \n                    https:\/\/doi.org\/10.1007\/s10067-010-1430-6","journal-title":"Clin Rheumatol"},{"issue":"4","key":"4325_CR90","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/1756-185X.12248","volume":"17","author":"F Davatchi","year":"2014","unstructured":"Davatchi F, Sadeghi Abdollahi B et al (2014) Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet\u2019s disease: longitudinal study of up to 10 years. Int J Rheum Dis 17(4):444\u2013452. \n                    https:\/\/doi.org\/10.1111\/1756-185X.12248","journal-title":"Int J Rheum Dis"},{"issue":"528","key":"4325_CR91","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/0-306-48382-3_100","volume":"3","author":"F Davatchi","year":"2003","unstructured":"Davatchi F, Shahram F, Chams H et al (2003) The influence of the delay of aggressive treatment on the vision and its outcome in Behcet\u2019s disease. Adv Exp Med Biol 3(528):493\u2013494. \n                    https:\/\/doi.org\/10.1007\/0-306-48382-3_100","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"4325_CR92","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1007\/s10067-016-3318-6","volume":"35","author":"H Kavandi","year":"2016","unstructured":"Kavandi H, Khabbazi A, Kolahi S, Hajialilo M, Shayan FK, Oliaei M (2016) Long-term efficacy and safety of interferon \u03b1-2a therapy in severe refractory ophthalmic Behcet\u2019s disease. Clin Rheumatol 35(11):2765\u20132769. \n                    https:\/\/doi.org\/10.1007\/s10067-016-3318-6","journal-title":"Clin Rheumatol"},{"issue":"12","key":"4325_CR93","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1111\/1756-185X.13109","volume":"21","author":"A Khabbazi","year":"2018","unstructured":"Khabbazi A, Karkon Shayan F, Ghojazadeh M et al (2018) Adherence to treatment in patients with Behcet\u2019s disease. Int J Rheum Dis 21(12):2158\u20132166. \n                    https:\/\/doi.org\/10.1111\/1756-185X.13109","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"4325_CR94","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejmg.2017.09.007","volume":"60","author":"N Ebadi","year":"2017","unstructured":"Ebadi N, Shakoori A, Razipour M et al (2017) The spectrum of familial Mediterranean fever gene (MEFV) mutations and genotypes in Iran, and report of a novel missense variant (R204H). Eur J Med Genet 60(12):701\u2013705. \n                    https:\/\/doi.org\/10.1016\/j.ejmg.2017.09.007","journal-title":"Eur J Med Genet"},{"key":"4325_CR95","doi-asserted-by":"publisher","first-page":"912137","DOI":"10.1155\/2015\/912137","volume":"2015","author":"F Salehzadeh","year":"2015","unstructured":"Salehzadeh F (2015) Familial Mediterranean fever in Iran: a report from FMF Registration Center. Int J Rheumatol 2015:912137. \n                    https:\/\/doi.org\/10.1155\/2015\/912137","journal-title":"Int J Rheumatol"},{"issue":"3","key":"4325_CR96","first-page":"169","volume":"12","author":"M Bagheri","year":"2017","unstructured":"Bagheri M, Rad IA (2017) Analysis of the most common three MEFV mutations in 630 patients with familial Mediterranean fever in Iranian Azeri Turkish Population. Maedica (Buchar) 12(3):169\u2013173","journal-title":"Maedica (Buchar)"},{"issue":"1","key":"4325_CR97","first-page":"50","volume":"3","author":"H Nobakht","year":"2011","unstructured":"Nobakht H, Zamani F, Ajdarkosh H, Mohamadzadeh Z, Fereshtehnejad S, Nassaji M (2011) Adult-onset familial mediterranean Fever in northwestern Iran; clinical feature and treatment outcome. Middle East J Dig Dis 3(1):50\u201355","journal-title":"Middle East J Dig Dis"},{"issue":"2","key":"4325_CR98","first-page":"152","volume":"15","author":"L Mohammadnejad","year":"2013","unstructured":"Mohammadnejad L, Farajnia S (2013) Mediterranean Fever gene analysis in the Azeri Turk population with familial Mediterranean fever: evidence for new mutations associated with disease. Cell J 15(2):152\u2013159","journal-title":"Cell J"},{"issue":"2","key":"4325_CR99","first-page":"32","volume":"33","author":"A Khabbazi","year":"2011","unstructured":"Khabbazi A, Pooraliakbari A, Hajialiloo M, Kolahi S, Sharif S (2011) Study of demographic, clinical and laboratory characteristics of palindromic rheumatism and its frequency in comparison with other inflammatory arthritis in North West of Iran. Med J Tabriz Univ Med Sci 33(2):32\u201336","journal-title":"Med J Tabriz Univ Med Sci"},{"issue":"4","key":"4325_CR100","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1756-185x.2012.01739.x","volume":"15","author":"A Khabbazi","year":"2012","unstructured":"Khabbazi A, Hajialiloo M, Kolahi S, Soroosh M, Esalatmanesh K, Sharif S (2012) A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int J Rheum Dis 15(4):427\u2013430. \n                    https:\/\/doi.org\/10.1111\/j.1756-185x.2012.01739.x","journal-title":"Int J Rheum Dis"},{"key":"4325_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reuma.2019.01.002","volume":"1","author":"A Khabbazi","year":"2019","unstructured":"Khabbazi A, Mirza-Aghazadeh-Attari M, Goli MT, Mahdavi AM, Hajialilo M, Rashtchizadeh N (2019) Is palindromic rheumatism a pre-rheumatoid arthritis condition? Low incidence of rheumatoid arthritis in palindromic rheumatism patients treated with tight control strategy. Rheumatol Clin 1:1. \n                    https:\/\/doi.org\/10.1016\/j.reuma.2019.01.002","journal-title":"Rheumatol Clin"},{"key":"4325_CR102","unstructured":"CINNAGEN. About us. \n                    https:\/\/www.cinnagen.com\/Timeline.aspx?l=3\n                    \n                  #. Last updated 7 Apr 2019. Accessed 10 May 2019"},{"key":"4325_CR103","unstructured":"ARYOGEN. About us. \n                    http:\/\/www.aryogen.com\/FA\/index.html\n                    \n                  . Last updated 7 Feb 2019. Accessed 10 May 2019"},{"issue":"1","key":"4325_CR104","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13075-017-1371-4","volume":"19","author":"A Jamshidi","year":"2017","unstructured":"Jamshidi A, Gharibdoost F, Vojdanian M et al (2017) A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA\u00ae) to the reference product (Humira\u00ae) in patients with active rheumatoid arthritis. Arthritis Res Ther 19(1):168. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1371-4","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"4325_CR105","first-page":"1336","volume":"47","author":"O Tabatabaei-Malazy","year":"2018","unstructured":"Tabatabaei-Malazy O, Norani M, Heshmat R, Qorbani M et al (2018) Efficacy and safety of the biosimilar recombinant human parathyroid hormone Cinnopar\u00ae in postmenopausal osteoporotic women: a randomized double-blind clinical trial. Iran J Public Health 47(9):1336\u20131344","journal-title":"Iran J Public Health"},{"issue":"2","key":"4325_CR106","first-page":"84","volume":"12","author":"G Toogeh","year":"2018","unstructured":"Toogeh G, Faranoush M, Razavi SM et al (2018) A double-blind, randomized comparison study between Zytux\u2122 vs MabThera\u00ae in treatment of CLL with FCR regimen: non-inferiority clinical trial. Int J Hematol Oncol Stem Cell Res 12(2):84\u201391","journal-title":"Int J Hematol Oncol Stem Cell Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04325-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04325-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04325-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:14:29Z","timestamp":1589843669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04325-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,20]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04325-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2019,5,20]]},"assertion":[{"value":"21 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors of this paper have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}